Back to
Invesco Ltd.
ENLV3 quarters
Position history for
Invesco Ltd.'s holdings in ENLIVEX THERAPEUTICS LTD
No. Invesco exited its ENLV (Enlivex Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 61,654 shares worth $57,344. Invesco first reported ENLV in Q4 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$42,839
Total Shares Change
-60,920
Quarter-by-Quarter History
Other major holders of ENLV: ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC